Prolight Diagnostics AB (publ) (NGM:PRLD)
18.30
0.00 (0.00%)
At close: Mar 6, 2026
Prolight Diagnostics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 | Upgrade
|
| Cash & Short-Term Investments | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 | Upgrade
|
| Cash Growth | 158.08% | 18.53% | -75.47% | 23.30% | -14.16% | Upgrade
|
| Other Receivables | 14.41 | 14.28 | 9.42 | 1.44 | 0.31 | Upgrade
|
| Receivables | 14.41 | 14.28 | 9.42 | 1.44 | 0.31 | Upgrade
|
| Prepaid Expenses | 2.79 | 0.1 | 0.16 | 1.29 | 2.06 | Upgrade
|
| Other Current Assets | - | - | - | - | 0 | Upgrade
|
| Total Current Assets | 57.81 | 30.12 | 22.85 | 56.84 | 46.25 | Upgrade
|
| Property, Plant & Equipment | 8.24 | 6.5 | 2.69 | 0.7 | - | Upgrade
|
| Other Intangible Assets | - | 1.86 | 87.79 | 24.95 | 1.84 | Upgrade
|
| Long-Term Deferred Charges | 127.29 | 127.86 | 24.7 | 125.43 | 101.04 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0 | 31.2 | - | - | Upgrade
|
| Total Assets | 193.43 | 166.33 | 169.23 | 207.91 | 149.13 | Upgrade
|
| Accounts Payable | 6.35 | 3.78 | 4.18 | 0.99 | 0.9 | Upgrade
|
| Accrued Expenses | 2.46 | 2.68 | 0.96 | 1.22 | 1.93 | Upgrade
|
| Other Current Liabilities | 0.85 | 13.79 | 13.32 | 0.29 | - | Upgrade
|
| Total Current Liabilities | 9.66 | 20.26 | 18.45 | 2.51 | 2.82 | Upgrade
|
| Other Long-Term Liabilities | 14.42 | 17.79 | 17.79 | - | - | Upgrade
|
| Total Liabilities | 24.08 | 38.05 | 36.24 | 2.51 | 2.82 | Upgrade
|
| Common Stock | 120.45 | 70.21 | 34.68 | 28.23 | 14.91 | Upgrade
|
| Additional Paid-In Capital | 279.88 | 237.87 | 237.23 | 195.6 | 125.48 | Upgrade
|
| Retained Earnings | -230.98 | - | - | - | 5.92 | Upgrade
|
| Comprehensive Income & Other | - | -179.79 | -138.92 | -18.43 | 0 | Upgrade
|
| Shareholders' Equity | 169.35 | 128.28 | 132.99 | 205.41 | 146.31 | Upgrade
|
| Total Liabilities & Equity | 193.43 | 166.33 | 169.23 | 207.91 | 149.13 | Upgrade
|
| Net Cash (Debt) | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 | Upgrade
|
| Net Cash Growth | 158.08% | 18.53% | -75.47% | 23.30% | -14.16% | Upgrade
|
| Net Cash Per Share | 3.42 | 2.66 | 4.69 | - | 29.43 | Upgrade
|
| Filing Date Shares Outstanding | 12.04 | 7.02 | 3.47 | 2.82 | 1.49 | Upgrade
|
| Total Common Shares Outstanding | 12.04 | 7.02 | 3.47 | 2.82 | 1.49 | Upgrade
|
| Working Capital | 48.14 | 9.86 | 4.41 | 54.33 | 43.43 | Upgrade
|
| Book Value Per Share | 14.06 | 18.27 | 38.35 | 72.77 | 98.13 | Upgrade
|
| Tangible Book Value | 169.35 | 126.42 | 45.21 | 180.46 | 144.47 | Upgrade
|
| Tangible Book Value Per Share | 14.06 | 18.01 | 13.03 | 63.93 | 96.89 | Upgrade
|
| Machinery | - | 8.99 | 3.69 | 0.92 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.